Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02674139
Other study ID # GO-MD-IUD
Secondary ID
Status Enrolling by invitation
Phase Phase 4
First received January 30, 2016
Last updated September 26, 2016
Start date February 2016
Est. completion date June 2017

Study information

Verified date September 2016
Source Beni-Suef University
Contact n/a
Is FDA regulated No
Health authority Egypt: Institutional Review BoardEgypt: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

The study aims to compare immediate post-placental (within 10 minutes of placenta delivery) intrauterine contraceptive device (Copper T 380A) insertion versus conventional placement at 6 weeks (often referred to as delayed or interval insertion) regarding the clinical outcomes (safety, efficacy, expulsion and continuation rates) for women undergoing caesarean section.


Description:

• Study Design: A controlled randomized clinical trial (CRCT)

• Study Site: The study will be carried out in the Department of Obstetrics and Gynecology at Beni-suef University Hospital

• Study Population: The study population will include pregnant women between 36-40 weeks gestational ages who attend antenatal care and are eligible for insertion of IUCD during delivery through elective caesarean section.

• Study Sample: The study will consist of 200 women which will be chosen randomly to whom elective lower segment caesarean section will be done at the Obstetrics and Gynecology department, willing to have an intrauterine device (IUD) inserted for postpartum contraception and willing to comply with the study protocol.

After informed consent is obtained, eligible study participants will be randomized into 2 groups:

Group (A): 100 Women will receive the Pregna ® IUD at the 6 week postpartum visit Group (B): 100 Women will receive the Pregna ® IUD within 10 minutes of delivery of the placenta during caesarean section.

• Study Procedure:

Insertion Technique:

During caesarean section:

Uterine cavity will be inspected for presence of malformations following placental delivery, which would limit use of IUCD.The IUCD (Pregna Copper T 380A) will be removed from the insertion sleeve and will be placed on the sterile field. Uterus is stabilized by grasping it at fundus. Insertion will be done during cesarean delivery, after ex pulsion of placenta and through the uterine incision, manually (IUCD is Held between middle and index finger). It will be inserted into the uterus through uterine incision and will be released at fundus of uterus. Hand will be removed slowly from the uterus. Enough care will be taken not to dislodge IUCD as hand is removed. Strings will be guided toward the lower uterine segment without disturbing IUCD'S fundal position. Enough Care will be taken not to include IUCD strings during uterine closure.

Delayed postpartum IUDs Will be inserted in the usual sterile fashion as described in the manufacturer's instructions at the 6-week postpartum visit

Later Prior to Discharge:

- IUCD Client card, showing type of IUCD and date of insertion will be given to patient.

- She will be informed about the IUCD side effects and normal postpartum symptoms.

- Patients will be scheduled for a control examination at 1 week, 6 weeks, 3 months and 6 months after the insertion.

- She will be advised to contact one of the physicians immediately if they experienced:-

- Unusual vaginal discharge different from the usual lochia.

- Lower abdominal pain, especially if accompanied by fever or chills.

- Feeling of being pregnant.

- Suspicion that the IUCD has fallen out.

Follow up visits:

- At each visit the patients will be questioned for symptoms of expulsion, excessive bleeding and infection. In addition, a pelvic examination (per speculum) and trans-vaginal ultrasound will be performed at each follow-up visit.

- In per speculum examination if IUD threads are long, they will be cut 2 cm from external os. If threads of IUD are not seen and there was no history of expulsion of IUD, pelvic ultrasonography or X-ray pelvis will be done to note for misplaced IUD.

- All the patients will subjected to the follow up:

- The IUD will be removed in the case of partial expulsion, bleeding or pain, or at the patient's request.

- Ethical Considerations

1-Approval by the institution ethical committee 2-Individual Consent Process: Written informed consent will be taken after explaining the study objective the procedures to potential participants. Participation will be voluntary and participants will be informed that the decision not to participate will not impact on the quality of care they receive.

- The statistical Analysis:

Data will be statistically described in terms of mean + standard deviation (+/- SD), frequencies (number of cases) and relative frequencies (percentages) when appropriate. Comparison of numerical variables between the study groups will be done using Student t test for independent samples. For comparing categorical data, Chi square (X2) test will be performed. Exact test will be used instead when the expected frequency is less than 5. P values less than 0.05 will be considered statistically significant.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 8
Est. completion date June 2017
Est. primary completion date March 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion criteria:

- Age: 18 - 45 years.

- GA 36-40 weeks based upon the date of last normal menstruation, confirmed by ultrasonographic scan.

- Desire to have intrauterine contraceptive device (Cu T) after counseling about different contraceptive options and consented to the study.

Exclusion criteria:

- Allergy to copper.

- Ante- or intra-partum hemorrhage.

- Hemorrhagic disorders.

- Current or past history of pelvic inflammatory disease.

- Women known to have pelvic TB.

- Known to have ruptured membranes for more than 24 h prior to delivery.

- History of chorioamnionitis.

- Known uterine abnormalities e.g., Bicornuate/septate Uterus, uterine myoma.

- Patients presented with febrile morbidity prior to the operation defined as temperature above 38'c.

- Multiple pregnancies.

- Placenta previa.

- History of ectopic pregnancy.

- Anemia (hemoglobin <10 g/dl).

- Cervical cancer or carcinoma in situ.

- Diagnosis of active cervical infection for standard insertion.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Copper T 380A IUD
intrauterine contraceptive device T-shaped loaded with cupper

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
sara AbdAllah Beni-Suef University

Outcome

Type Measure Description Time frame Safety issue
Primary Expulsion: Complete IUD expulsion will be verified clinically and by transvaginal ultrasound Complete IUD expulsion will be verified clinically and by transvaginal ultrasound. An IUD will be considered to be partially expelled if a distance greater than 10 mm is measured between the vertical arm of the IUD and the junction between the endometrium and the uterine cavity) 6 months Yes
Secondary Uterine perforation (assessed by pelvic ultrasonography or X-ray) To be assessed by pelvic ultrasonography or X-ray pelvis will to note for misplaced IUD 6 months Yes
Secondary Pelvic pain (using the 0-10 Numeric Pain Rating Scale) Using the 0-10 Numeric Pain Rating Scale and analgesic doses required 6 months No
Secondary Strings not visible (assessed by speculum examination) To be assessed by speculum examination. 6 months No
Secondary Pelvic infection: number of participants with Pelvic infection number of participants with Pelvic infection 6 months Yes
Secondary Psychological (satisfied or not) using questionnaire using questionnaire 6 months No
Secondary Pregnancy (assessed by serum pregnancy test and pelvic ultrasound) To be assessed by serum pregnancy test and pelvic ultrasound in suspicious cases (missed period - misplaced IUD - expelled IUCD either partial or complete) 6 months No
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A